01The Goal

Prevent the brain’s decline before health is ever lost

The goal is to prevent the loss of the brain — stopping the damage behind Alzheimer’s, dementia, and cognitive decline before it ever takes hold — so a person keeps their memory, their thinking, and their self, and never has to lose them in the first place.

02Why This Matters

Dementia is one of the most feared diagnoses in medicine, and one of the cruelest: it takes people while they are still here, and it falls just as heavily on the families who watch it happen. The deepest victory is not a better way to manage that loss — it is for the loss never to occur. Neuroprotection is squarely the Healthy mission: not coping with decline, but preventing it. The honest, powerful news is how much prevention is already in reach: the 2024 Lancet Commission estimates that about 45% of dementia cases could be prevented or delayed by acting on 14 modifiable risk factors across life.

03What We’re Building

We are building the capability to prevent brain health loss: removing the modifiable drivers of neurodegeneration before they cause damage, protecting the brain’s own defense and clearance systems, and — at the frontier — protecting neurons directly so the brain is defended at its foundation. This is about prevention in the truest sense: keeping the brain healthy so the loss never happens.

04How It Works

Preventing the loss before it begins

Removing modifiable risk Demonstrated — clinical

The evidence: The 2024 Lancet Commission ties ~45% of dementia risk to 14 factors across life — education, hearing, vision, depression, social engagement, physical activity, head-injury protection, blood sugar, cholesterol, healthy weight, blood pressure, not smoking, limited alcohol, and clean air. Restoring those healthy states genuinely prevents health loss at the population level — reached, wherever possible, by addressing root causes rather than trading one problem for another, and made freely available at the point of need.

Protecting the brain’s vascular base Demonstrated — clinical

The evidence: Much brain decline is vascular. Protecting healthy blood pressure, cholesterol, and circulation prevents a major share of cognitive loss — proven, accessible prevention that links to cardiovascular health.

Protecting sleep & the brain’s clearance Demonstrated — clinical

The science: During deep sleep the brain runs its own waste-clearance process (the glymphatic system), flushing out the proteins tied to neurodegeneration. Protecting healthy sleep — and treating disorders like sleep apnea — removes a real driver of decline. See Healthy Sleep. (Scientists still debate exactly how much clearance happens in sleep vs waking; we follow the evidence honestly.)

Building cognitive reserve Demonstrated — clinical

The evidence: A mentally and physically active life — learning, education, engagement — literally builds cognitive reserve, the brain’s resilience that delays the onset of decline. This is the optimize dimension: not just preventing damage, but strengthening the brain so it withstands more. Links to cognitive preservation and human connection.

Protecting the brain’s environment Demonstrated — clinical

The evidence: Air pollution is one of the 14 Lancet modifiable factors — fine particulates are tied to dementia risk. Protecting the air people breathe protects the brain, a direct Free improving Healthy connection to clean-air infrastructure. Prevention at the level of the environment itself.

Social connection & engagement Demonstrated — clinical

The evidence: Strong social connection supports cognitive reserve and is associated with protection against cognitive decline — while isolation tracks with higher risk. A genuine, accessible prevention mechanism, and a direct link to the Free pillar’s human connection & community capability.

Lowering chronic inflammation Clinical

The science: Chronic inflammation and chronic stress are increasingly tied to neurodegeneration. Calming them — through the body’s own balance, not harsh intervention — protects the brain over time. A genuine prevention lever, honestly still being mapped.

Protecting metabolic & brain-energy health Clinical

The science: The brain is energy-hungry, and metabolic health and cellular energy shape its resilience. Protecting healthy blood sugar and mitochondrial function helps defend the brain — prevention at the level of the brain’s fuel supply.

Protecting neurons directly Frontier

The frontier: Approaches that shield neurons from the processes that kill them in neurodegeneration aim at prevention at the foundation — keeping brain tissue from being lost at all. Advancing in the lab; not yet proven in people, and we say so plainly. Connects to neuroregeneration.

Catching loss before it starts Clinical

The capability: Early detection is not itself a cure — it is the gateway to prevention. The first FDA-cleared Alzheimer’s blood tests (2024) flag risk years before symptoms, opening the window in which prevention can actually keep health from being lost.

05Who Is Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & public research

the National Institute of Neurological Disorders and Stroke (NINDS, NIH) and the National Institute on Aging (NIA, NIH), which fund the majority of dementia-prevention research, plus the federal National Plan to Address Alzheimer’s Disease coordinating national prevention strategy.

Standing scientific bodies

The Lancet standing Commission on Dementia Prevention, Intervention and Care (2024) — the authoritative synthesis of modifiable-risk evidence — and the Alzheimer’s Association, which funds and tracks prevention science.

Prevention-trial networks

The FINGER trial and the World-Wide FINGERS network, testing structured multidomain prevention across populations globally — the largest coordinated test of dementia prevention to date.

Sleep & clearance researchers

Academic centers studying the glymphatic system and sleep’s role in clearing neurodegeneration-related proteins — an active, fast-moving field with human trials underway.

Vascular & metabolic brain-health science

Cardiovascular and metabolic researchers establishing how blood-pressure, cholesterol, and blood-sugar control protect the brain — the evidence base behind vascular prevention.

Enabling science

modifiable-risk epidemiology · blood-based risk biomarkers · vascular and metabolic brain-health research · glymphatic/sleep neuroscience · cognitive-reserve research · frontier neuroprotection biology.

06The Technologies

The technologies of prevention span the accessible and the frontier. Modifiable-risk medicine — treating blood pressure, cholesterol, hearing and vision loss before they erode the brain — is available today and carries the largest population benefit. Structured prevention programs (FINGER and its global successors) combine diet, exercise, cognitive, and vascular care into proven multidomain protocols. Blood-based risk detection opens the prevention window years earlier. Sleep and circadian science protects the brain’s own glymphatic clearance. Vascular and metabolic care defends the brain’s blood supply and energy, while clean-air infrastructure protects the environment it lives in. And at the frontier, direct neuroprotection aims to shield neurons themselves — advancing in the lab, honestly not yet proven in people.

07The Breakthroughs

Prevention is partly real today Demonstrated — clinical

The Lancet Commission’s ~45% finding means preventing dementia is not a someday hope — a large share of loss is preventable now, through care people can actually access.

Structured prevention works Clinical

Multidomain prevention programs (FINGER, now tested worldwide) show real cognitive benefit in at-risk older adults — honest, moderate effects, squarely preventive.

Sleep-driven brain clearance shown in people Clinical

A 2026 human crossover trial found normal sleep increased overnight clearance of Alzheimer’s-related proteins versus sleep deprivation — direct human evidence that protecting sleep helps prevent buildup.

Earlier window for prevention Clinical

FDA-cleared blood tests (2024) detect risk years before symptoms — turning ‘wait and see’ into a window where loss can be prevented.

Vascular prevention is established Demonstrated — clinical

Decades of cardiovascular evidence show protecting blood pressure and cholesterol prevents a major share of cognitive decline — among the most reliable levers we have.

Cognitive reserve delays onset Demonstrated — clinical

Education and lifelong mental and physical engagement measurably build resilience that delays decline — strengthening the brain, not just shielding it.

Cleaner air protects the brain Demonstrated — clinical

Air pollution is an established modifiable dementia risk factor — reducing exposure removes a real environmental driver of brain decline.

Social connection builds reserve Demonstrated — clinical

Social engagement supports cognitive reserve and is associated with protection against decline — connection is a real, accessible prevention lever.

Direct neuroprotection advancing Frontier

Lab science aimed at shielding neurons from neurodegeneration is progressing — promising, foundational, and honestly not yet proven in people.

08The Challenges

The honest challenges: dementia cannot yet be reliably prevented — prevention shifts the odds powerfully but does not guarantee any one person’s outcome. Removing modifiable risk is real and clinical; direct neuroprotection of neurons is frontier. We are also strict about the boundary of this page: therapies that only slow decline once disease has set in — or that carry their own health risks — belong to current care, not to the Healthy mission of preventing loss without creating new harm. We do not include them here. The focus here is prevention — protecting the brain so health is kept, not lost — pursued with an honest account of where the science genuinely stands today.

09The Goal, Fully Built

The future, fully built

A person never loses their brain to dementia in the first place: risk identified early through a simple blood test, modifiable drivers removed before they cause damage, the vascular base and sleep-clearance protected, cognitive reserve built, and — as the science matures — neurons shielded directly. The loss of memory and self becomes something we prevent — so a grandparent stays present at the table with the people who love them.

Honest boundary: each item is tagged demonstrated, clinical, or frontier. Neuroprotection here means preventing health loss — not managing disease after it sets in. The science is real and accelerating, but dementia cannot yet be reliably prevented, and direct neuroprotection remains frontier. AI supports human clinicians; it never replaces them.
10The Evidence

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Modifiable-risk prevention (Lancet 2024)Demonstrated (clinical/epidemiological)

The standing Lancet Commission estimates ~45% of dementia cases are preventable or delayable by addressing 14 modifiable risk factors across life (adding high LDL cholesterol and untreated vision loss in 2024).

Structured prevention (FINGER)Clinical

The Finnish FINGER trial showed cognitive benefit from a multidomain prevention program in at-risk older adults; now tested globally via World-Wide FINGERS.

Earlier detection enabling preventionClinical

The first FDA-cleared Alzheimer’s blood tests (2024) match amyloid PET more than 90% of the time, widening the window for prevention.

Sleep & glymphatic clearanceDemonstrated / Clinical

Deep non-REM sleep supports the brain’s glymphatic clearance of amyloid-beta and tau; a 2026 human trial showed normal sleep raised overnight clearance of these proteins vs sleep deprivation. Exact sleep-vs-wake contribution is still debated.

Vascular brain protectionDemonstrated (clinical)

Decades of evidence link blood-pressure and cholesterol control to prevention of a major share of cognitive decline.

Air pollution as modifiable riskDemonstrated (clinical/epidemiological)

The 2024 Lancet Commission includes air pollution among 14 modifiable dementia risk factors; reducing fine-particulate exposure is protective.

Social connection & cognitive reserveDemonstrated (clinical/epidemiological)

Social engagement is associated with greater cognitive reserve and protection against cognitive decline; isolation tracks with higher risk.

Direct neuroprotectionFrontier

Shielding neurons from neurodegeneration is advancing in the lab; not yet proven in people.

Honest framing

Real organizations, trials, and approvals are cited as evidence the capability is real — not as partners or endorsers. Items that merely manage or slow disease, or that carry their own health risks, are not presented as Healthy-pillar capabilities.

Help build this future

Every signature grows the movement to make brain protection real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top